Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.
If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the "fungus ball" is indicated. The disease must be monitored carefully for any signs of reemergence.
Market Analysis and Insights: Global Mucormycosis Market
The research report studies the Mucormycosis market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Mucormycosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Mucormycosis Scope and Segment
The global Mucormycosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mucormycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Diagnosis, the market is primarily split into
Computed Tomography (CT)
Magnetic resonance imaging (MRI)
Tissue Biopsy
Others
by Application, this report covers the following segments
Hospitals & Clinics
Medical Institutes
Research Organization
Others
Global Mucormycosis market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Mucormycosis key players in this market include:
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the "fungus ball" is indicated. The disease must be monitored carefully for any signs of reemergence.
Market Analysis and Insights: Global Mucormycosis Market
The research report studies the Mucormycosis market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Mucormycosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Mucormycosis Scope and Segment
The global Mucormycosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mucormycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Diagnosis, the market is primarily split into
Computed Tomography (CT)
Magnetic resonance imaging (MRI)
Tissue Biopsy
Others
by Application, this report covers the following segments
Hospitals & Clinics
Medical Institutes
Research Organization
Others
Global Mucormycosis market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Mucormycosis key players in this market include:
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
1 Market Overview of Mucormycosis
1.1 Mucormycosis Market Overview
1.1.1 Mucormycosis Product Scope
1.1.2 Market Status and Outlook
1.2 Global Mucormycosis Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Mucormycosis Market Size by Region (2015-2026)
1.4 Global Mucormycosis Historic Market Size by Region (2015-2020)
1.5 Global Mucormycosis Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Mucormycosis Market Size YoY Growth (2015-2026)
1.6.1 North America Mucormycosis Market Size YoY Growth (2015-2026)
1.6.2 Europe Mucormycosis Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Mucormycosis Market Size YoY Growth (2015-2026)
1.6.4 Latin America Mucormycosis Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Mucormycosis Market Size YoY Growth (2015-2026)
2 Mucormycosis Market Overview by Diagnosis
2.1 Global Mucormycosis Market Size by Diagnosis: 2015 VS 2020 VS 2026
2.2 Global Mucormycosis Historic Market Size by Diagnosis (2015-2020)
2.3 Global Mucormycosis Forecasted Market Size by Diagnosis (2021-2026)
2.4 Computed Tomography (CT)
2.5 Magnetic resonance imaging (MRI)
2.6 Tissue Biopsy
2.7 Others
3 Mucormycosis Market Overview by Application
3.1 Global Mucormycosis Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Mucormycosis Historic Market Size by Application (2015-2020)
3.3 Global Mucormycosis Forecasted Market Size by Application (2021-2026)
3.4 Hospitals & Clinics
3.5 Medical Institutes
3.6 Research Organization
3.7 Others
4 Global Mucormycosis Competition Analysis by Players
4.1 Global Mucormycosis Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucormycosis as of 2019)
4.3 Date of Key Manufacturers Enter into Mucormycosis Market
4.4 Global Top Players Mucormycosis Headquarters and Area Served
4.5 Key Players Mucormycosis Product Solution and Service
4.6 Competitive Status
4.6.1 Mucormycosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Mucormycosis Products, Services and Solutions
5.1.4 Abbott Laboratories Mucormycosis Revenue (US$ Million) & (2015-2020)
5.1.5 Abbott Laboratories Recent Developments
5.2 Biocon
5.2.1 Biocon Profile
5.2.2 Biocon Main Business
5.2.3 Biocon Mucormycosis Products, Services and Solutions
5.2.4 Biocon Mucormycosis Revenue (US$ Million) & (2015-2020)
5.2.5 Biocon Recent Developments
5.3 Cadila Pharmaceuticals
5.5.1 Cadila Pharmaceuticals Profile
5.3.2 Cadila Pharmaceuticals Main Business
5.3.3 Cadila Pharmaceuticals Mucormycosis Products, Services and Solutions
5.3.4 Cadila Pharmaceuticals Mucormycosis Revenue (US$ Million) & (2015-2020)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Mucormycosis Products, Services and Solutions
5.4.4 Novartis Mucormycosis Revenue (US$ Million) & (2015-2020)
5.4.5 Novartis Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Mucormycosis Products, Services and Solutions
5.5.4 Merck Mucormycosis Revenue (US$ Million) & (2015-2020)
5.5.5 Merck Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Mucormycosis Products, Services and Solutions
5.6.4 Roche Mucormycosis Revenue (US$ Million) & (2015-2020)
5.6.5 Roche Recent Developments
5.7 Bristol Myers Squibb
5.7.1 Bristol Myers Squibb Profile
5.7.2 Bristol Myers Squibb Main Business
5.7.3 Bristol Myers Squibb Mucormycosis Products, Services and Solutions
5.7.4 Bristol Myers Squibb Mucormycosis Revenue (US$ Million) & (2015-2020)
5.7.5 Bristol Myers Squibb Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Mucormycosis Products, Services and Solutions
5.8.4 Pfizer Mucormycosis Revenue (US$ Million) & (2015-2020)
5.8.5 Pfizer Recent Developments
6 North America
6.1 North America Mucormycosis Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Mucormycosis Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mucormycosis Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mucormycosis Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mucormycosis Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mucormycosis Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Mucormycosis Market Overview
1.1.1 Mucormycosis Product Scope
1.1.2 Market Status and Outlook
1.2 Global Mucormycosis Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Mucormycosis Market Size by Region (2015-2026)
1.4 Global Mucormycosis Historic Market Size by Region (2015-2020)
1.5 Global Mucormycosis Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Mucormycosis Market Size YoY Growth (2015-2026)
1.6.1 North America Mucormycosis Market Size YoY Growth (2015-2026)
1.6.2 Europe Mucormycosis Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Mucormycosis Market Size YoY Growth (2015-2026)
1.6.4 Latin America Mucormycosis Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Mucormycosis Market Size YoY Growth (2015-2026)
2 Mucormycosis Market Overview by Diagnosis
2.1 Global Mucormycosis Market Size by Diagnosis: 2015 VS 2020 VS 2026
2.2 Global Mucormycosis Historic Market Size by Diagnosis (2015-2020)
2.3 Global Mucormycosis Forecasted Market Size by Diagnosis (2021-2026)
2.4 Computed Tomography (CT)
2.5 Magnetic resonance imaging (MRI)
2.6 Tissue Biopsy
2.7 Others
3 Mucormycosis Market Overview by Application
3.1 Global Mucormycosis Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Mucormycosis Historic Market Size by Application (2015-2020)
3.3 Global Mucormycosis Forecasted Market Size by Application (2021-2026)
3.4 Hospitals & Clinics
3.5 Medical Institutes
3.6 Research Organization
3.7 Others
4 Global Mucormycosis Competition Analysis by Players
4.1 Global Mucormycosis Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucormycosis as of 2019)
4.3 Date of Key Manufacturers Enter into Mucormycosis Market
4.4 Global Top Players Mucormycosis Headquarters and Area Served
4.5 Key Players Mucormycosis Product Solution and Service
4.6 Competitive Status
4.6.1 Mucormycosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Mucormycosis Products, Services and Solutions
5.1.4 Abbott Laboratories Mucormycosis Revenue (US$ Million) & (2015-2020)
5.1.5 Abbott Laboratories Recent Developments
5.2 Biocon
5.2.1 Biocon Profile
5.2.2 Biocon Main Business
5.2.3 Biocon Mucormycosis Products, Services and Solutions
5.2.4 Biocon Mucormycosis Revenue (US$ Million) & (2015-2020)
5.2.5 Biocon Recent Developments
5.3 Cadila Pharmaceuticals
5.5.1 Cadila Pharmaceuticals Profile
5.3.2 Cadila Pharmaceuticals Main Business
5.3.3 Cadila Pharmaceuticals Mucormycosis Products, Services and Solutions
5.3.4 Cadila Pharmaceuticals Mucormycosis Revenue (US$ Million) & (2015-2020)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Mucormycosis Products, Services and Solutions
5.4.4 Novartis Mucormycosis Revenue (US$ Million) & (2015-2020)
5.4.5 Novartis Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Mucormycosis Products, Services and Solutions
5.5.4 Merck Mucormycosis Revenue (US$ Million) & (2015-2020)
5.5.5 Merck Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Mucormycosis Products, Services and Solutions
5.6.4 Roche Mucormycosis Revenue (US$ Million) & (2015-2020)
5.6.5 Roche Recent Developments
5.7 Bristol Myers Squibb
5.7.1 Bristol Myers Squibb Profile
5.7.2 Bristol Myers Squibb Main Business
5.7.3 Bristol Myers Squibb Mucormycosis Products, Services and Solutions
5.7.4 Bristol Myers Squibb Mucormycosis Revenue (US$ Million) & (2015-2020)
5.7.5 Bristol Myers Squibb Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Mucormycosis Products, Services and Solutions
5.8.4 Pfizer Mucormycosis Revenue (US$ Million) & (2015-2020)
5.8.5 Pfizer Recent Developments
6 North America
6.1 North America Mucormycosis Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Mucormycosis Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mucormycosis Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mucormycosis Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mucormycosis Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mucormycosis Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
